INS and type 1 diabetes mellitus: The occurrence of residual endogenous insulin secretion in patients with T1D has been linked to reduced risk for severe hypoglycemia (63, 64), reduced development of diabetic retinopathy (65), promotion of statural growth in prepubertal children (66) and reduced risk for long-term complications of T1D (12, 17).